Multiple machine learning models for predicting major adverse cardiovascular events in dialysis with clinical and echocardiographic parameters: a retrospective cohort study
Elevated NT-proBNP, advanced age, reduced eGFR and impaired GLS were independently associated with an increased risk of MACE in patients undergoing dialysis.
Abstract
Abstract Background Patients undergoing dialysis are at an elevated risk of cardiovascular events. This study aimed to develop machine learning (ML) prediction models to identify risk factors for major adverse cardiovascular events (MACE) in dialysis patients. Materials and Methods This retrospective study included 203 patients undergoing dialysis with a median age of 45.0 years and 64.0% male. The participants were divided into training and test sets in a 7:3 ratio. LASSO regression selected characteristic variables from patients’general information, laboratory tests, and echocardiographic parameters (including global longitudinal strain [GLS]). Eight ML models were constructed,and SHAP analysis evaluated feature importance. Results The incidence of MACE (including myocardial infarction, unstable angina, heart failure, and cardiovascular death) in dialysis patients was 38.92%. The average follow-up period was 18 months. LASSO regression identified eight feature variables. Among the ML models, AdaBoost demonstrated superior performance, with an AUC of 0.883 (95% CI: 0.830–0.937), accuracy of 0.804, sensitivity of 0.864 and specificity of 0.762 in the training set, and an AUC of 0.809 (95% CI: 0.706–0.912), accuracy of 0.750, sensitivity of 0.90 and specificity of 0.675 in the test set. The SHAP analysis identified N-terminal pro-brain natriuretic peptide (NT-proBNP) level, estimated glomerular filtration rate (eGFR), GLS and age as the four most important features for predicting MACE in patients undergoing dialysis (mean absolute SHAP values: 0.199, 0.176, 0.096 and 0.091, respectively). Conclusion Elevated NT-proBNP, advanced age, reduced eGFR and impaired GLS were independently associated with an increased risk of MACE in patients undergoing dialysis.
An interpretable logistic regression model based on seven routine clinical variables showed relatively good internal performance for predicting 1-year composite MACE risk in hospitalized patients with coexisting T2DM and HTN.
Juan Lv, Xi-Rui Wang, Zheng-Yi Zhang· Frontiers in Medicine· 0 citations
The use of a structured machine learning approach to predict 30-day mortality in patients with acute and chronic CAD demonstrated promising discriminative performance, providing valuable insights that could enhance personalized care and inform clinical decisions.
Septi Melisa, P. Phan, Sheng-Hsuan Chien et al.· International Journal of Car...· 0 citations
The Random Forest model demonstrated moderate discrimination for predicting in-hospital adverse events in CHD patients undergoing cardiac surgery and the developed web application provides real-time risk assessment with model interpretability features, enabling clinicians to input patient data and obtain immediate, cal...
Creatinine-based eGFR showed a stronger observed association with 1-year MACE after PCI than cystatin C–based eGFR in this single-center cohort; these findings do not establish clinical superiority of either equation and require external validation.
Yi-Cheng Wang, Fang-Ming Liu, Ruo-Xi Qi et al.· Frontiers in Cardiovascular...· 0 citations
Age, fasting blood glucose, absolute handgrip strength, and left ventricular ejection fraction are independent predictors of MACE in patients receiving PD in a novel, interpretable nomogram-based risk prediction model that demonstrates high discriminative accuracy, calibration fidelity, and clinical utility.
Jing Han, Xiao-Li Guo, Xue-Jiao Liu et al.· Frontiers in Nephrology· 0 citations
ML-based models enabled accurate prediction of IHM in patients with NSTE-ACS at different stages of the diagnostic process and may improve risk stratification and clinical decision-making in real-world practice.
V. V. Ryabov, A. Nesova, A. Vishnevskiy et al.· JMIR Medical Informatics· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.